I want Wegovy: here's how to get it safely in the UK

Step 1, work out whether you are likely to be eligible

Before anything else, it helps to know roughly where you stand. Wegovy's UK licence covers adults with a BMI of 30 or above, or a BMI of 27 to 29.9 alongside a weight-related condition. That condition could be prediabetes, diagnosed hypertension, obstructive sleep apnoea, raised cholesterol or osteoarthritis, among others. BMI thresholds are adjusted downward by around 2.5 kg/m² for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean heritage under current UK guidance.

The NHS BMI calculator takes under a minute to use and gives you a starting reference point, worth checking before you fill in any form, just so the number isn't a surprise. Keep in mind that BMI is one factor among several. A prescriber also looks at your medical history, existing medications and any contraindications before making a decision. Being in the BMI range doesn't guarantee approval; falling just outside it doesn't automatically rule you out if a weight-related condition is present.

Wegovy is not recommended during pregnancy, while breastfeeding or if you are actively trying to conceive. It is also not licensed for anyone under 18. If any of those apply to you right now, a prescriber is the right person to discuss timing and alternatives.

Step 2, choose a route: NHS waiting list or a registered private pharmacy

There are two legitimate routes to Wegovy in the UK, and they work very differently in practice. On the NHS, Wegovy is available through specialist weight management services under NICE's guidance (NICE technology appraisal TA875), but criteria are specific (a BMI of 35 or above with at least one weight-related comorbidity and access to a multidisciplinary specialist service) and waiting lists in many areas are long. It is also approved for a maximum of two years under the NHS pathway.

The private route, through a GPhC-registered pharmacy, means no referral and no waiting list. You complete a clinical consultation, a qualified prescriber reviews your answers the same day, and if you are suitable, your prescription is issued and your medication is dispatched. You can explore what private weight-loss treatments look like through a regulated service to understand how the process compares.

One thing to be cautious about: sellers on social media or websites offering Wegovy without a prescription are operating outside the law. The MHRA has warned repeatedly about counterfeit weight-loss pens, some fake products have been found to contain insulin. If a price looks far below what you'd expect, or no clinical assessment is mentioned anywhere, treat that as a serious red flag. Any pharmacy you use should be verifiable on the GPhC register.

Step 3, the consultation and what to expect from it

A genuine online consultation for Wegovy is not a checkbox exercise. At nume (sorry, at a service like this one) a GPhC-registered Independent Prescriber reads your answers personally. That means a real clinician looks at your health history, current medications, BMI and any relevant conditions before a prescription is issued. At nume, that review happens the same day as your consultation, and your prescriber follows MHRA guidance and clinical best practice, not an algorithm.

During the assessment you'll be asked about your weight history, any existing health conditions, what medicines you take and whether you've used GLP-1 treatments before. Transfer patients (people already established on Wegovy elsewhere) are asked to provide evidence of their current dose, so any increase is reviewed safely.

If the prescriber approves treatment, Wegovy is dispensed through our GPhC-registered UK pharmacy (registration number 9012878, verifiable at the GPhC register) and dispatched the same day for orders placed before 12pm Monday to Friday. Delivery is free and tracked via DPD, arriving the next working day in plain, unbranded packaging. Details on what the cost of Wegovy actually covers are worth reading before you decide, one transparent price includes consultation, prescription, delivery and aftercare.

Side effects and what to watch for once treatment starts

Most people starting Wegovy notice some gastrointestinal effects in the first weeks, nausea is the most common, along with looser stools, indigestion or burping. These tend to be most noticeable after dose increases and usually settle as your body adjusts. Some people find persistent wind or bloating catches them off guard; that page goes into detail on managing it.

The dose titration schedule exists partly to reduce these effects. Treatment begins at 0.25 mg with the first Wegovy dose level, rising through the second stage of the titration and several further steps to the 2.4 mg maintenance dose, with each level held for around four weeks. Your prescriber manages that process; the patient information leaflet that comes with your pen covers the full schedule and storage instructions. If you ever experience severe, persistent stomach pain that radiates to your back, seek urgent medical help, this can be a sign of pancreatitis, which the MHRA flagged specifically in a Drug Safety Update in January 2026.

Any suspected side effect can be reported directly to the MHRA via the Yellow Card scheme. Our clinical team is available seven days a week if you have questions during treatment, and if you are curious about whether microdosing semaglutide might suit you, you can read through that guidance before reaching us through our contact page.